Bioisosterism: A Rational Approach in Drug Design
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 96 (8) , 3147-3176
- https://doi.org/10.1021/cr950066q
Abstract
No abstract availableThis publication has 110 references indexed in Scilit:
- Multiple GABAB receptorsTrends in Pharmacological Sciences, 1993
- A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing propertiesJournal of Medicinal Chemistry, 1992
- Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine](sulfato)platinum(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic propertiesJournal of Medicinal Chemistry, 1990
- Molecular design, synthesis, and antiinflammatory activity of a series of .beta.-aminoxypropionic acidsJournal of Medicinal Chemistry, 1990
- Organic phosphorus compounds. 2. Synthesis and coronary vasodilator activity of (benzothiazolylbenzyl)phosphonate derivativesJournal of Medicinal Chemistry, 1989
- Cyclic carbamate analogs of pilocarpineJournal of Medicinal Chemistry, 1989
- Structure of leukotriene C identification of the amino acid partBiochemical and Biophysical Research Communications, 1979
- Molecular orbital studies on the mechanism of drug-receptor interaction. 2. .beta.-Adrenergic drugs. An approach to explain the role of the aromatic moietyJournal of Medicinal Chemistry, 1977
- Labetalol, an α- and β-adrenergic blocking drugin the treatment of hypertensionAmerican Heart Journal, 1977
- Some Analogs of HexestrolJournal of the American Chemical Society, 1943